Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Thursday - 7 November 2024

Thursday, 7 November 2024

Ceisteanna (442)

Steven Matthews

Ceist:

442. Deputy Steven Matthews asked the Minister for Health the steps that are being taken for polycythemia vera patients who rely on Pegasys (peginterferon alfa-2a) to manage this condition and who are now affected by a Pegasys shortage that was announced by the Health Products Regulatory Authority on 1 August 2024. [45620/24]

Amharc ar fhreagra

Freagraí scríofa

As this query relates to the clinical management of patients, the Deputy's question has been referred to the Health Service Executive for their attention and direct response.

Roinn